在癌症诊断中的因果解释性AI:进步,挑战和未来方向
概括
因果可解释的人工智能 (CXAI) 通过使人工智能 (AI) 模型在癌症诊断方面更加可靠和透明来增强瘤学. 这种方法提高了可靠性和临床相关性,解决了当前AI方法的局限性.
科学领域:
- 在瘤学瘤学.
- 人工智能 (AI) 是一种人工智能.
- 因果推理因果推理
- 可解释的人工智能 (XAI)
背景情况:
- 人工智能正在通过改进的癌症检测,诊断和个性化治疗来彻底改变瘤学.
- 人工智能的临床采用受到"黑子"模型的不透明性所限制,这引发了对可靠性,问责制和道德方面的担忧.
- 可解释的人工智能 (XAI) 提供解决方案,但面临着诸如低保真度,公平洗和易受偏见和虚假相关性的挑战.
研究的目的:
- 为癌症诊断提供第一个专门针对因果可解释AI (CXAI) 的全面审查.
- 通过整合因果推理来解决瘤学当前AI和XAI方法的缺陷.
- 探索当前的应用,确定挑战,并提出CXAI在癌症诊断中的未来方向.
主要方法:
- 综合文献综述,重点关注CXAI在瘤学中的应用.
- 综合现有关于医疗保健中的因果关系,可解释性和人工智能的研究,重点是癌症诊断.
- 分析CXAI提高模型稳定性,公平性和临床相关性的潜力.
主要成果:
- CXAI利用因果推理来克服传统XAI的局限性,提高AI模型的稳定性,公平性和瘤学中的临床相关性.
- 该评论总结了CXAI在各种癌症类型中的应用,强调其使人工智能驱动的瘤学更加透明和有效的潜力.
- 通过在医疗数据中捕捉因果关系,提高预测准确性和将AI见解与临床推理对齐,CXAI改善了临床决策.
结论:
- CXAI代表了一项重大进步,为癌症诊断中的人工智能提供了一种更可靠,更透明的方法.
- 通过提高透明度和信任,CXAI有助于在瘤学中采用AI,从而使得诊断决策和个性化患者护理更为明智.
- 未来的研究应该专注于进一步开发和验证CXAI方法,以充分发挥其在临床瘤学的潜力.
相关概念视频
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
Criteria for Causality: Bradford Hill Criteria - II
1.1K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.1K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
